Our Team

Dani Wilder is the Founder and Managing Director of nCase Technologies, where she leads strategy, product development, and long-term vision at the intersection of medicine, innovation, and public health. A fourth-year medical student at Washington University School of Medicine in St. Louis, Dani has built her career around solving real-world clinical problems through design and systems thinking. She graduated summa cum laude from Washington University with a research emphasis in Biology and has consistently bridged scientific rigor with entrepreneurial execution. Before founding nCase, Dani independently conceived, designed, and engineered a consumer medical product that earned finalist recognition in the Skandalaris Venture Competition and won the Quatrano Prize for creativity and research excellence. She later worked in healthcare education technology, transforming complex medical concepts into accessible, high-impact learning tools. Under Dani’s leadership, nCase has become an award-winning venture, recognized by Arch Grants, Sling Health, and the Skandalaris Venture Competition. The company’s flagship product – a streamlined naloxone carrying case – is grounded in harm reduction and built to integrate emergency preparedness into everyday life. Dani’s work is driven by a core belief: preparedness should not depend on circumstance. It should be designed into the systems we live in.

Matt Bitner-Glindzicz is the Founder and CEO of nCase Technologies, where he leads product engineering, strategy, capital formation, and national expansion. Trained as a mechanical and materials engineer, Matt previously managed $2M+ in NASA and Department of Energy–funded programs, designing sensor systems built to operate in extreme environments – from deep-sea mineral exploration to Mars-class planetary simulation. His work required precision engineering, systems integration, and full lifecycle execution from concept through field validation. He brought that same discipline to nCase. In under 11 months, Matt took the NALOX-1 from napkin sketch to market-ready, research-validated product. He led end-to-end execution: industrial design, tooling, offshore manufacturing, field trials, PR, sales, and fulfillment. Under his leadership, nCase has raised over $270,000 in pre-seed capital, secured $75,000 in non-dilutive funding from Arch Grants, generated strong organic revenue without paid advertising, and expanded distribution nationwide. Matt believes the most powerful innovations are not complex – they are frictionless. His work focuses on embedding life-saving preparedness into everyday behavior through simple, scalable design.

Rachel Rothstein is the Director of Public Health, Research, and Education at nCase Technologies, where she leads educational strategy, institutional training initiatives, and research efforts to expand access to life-saving naloxone. A Board Certified Health & Wellness Coach and Emergency Medical Technician with over a decade of frontline experience, Rachel has responded to opioid overdoses since her teenage years. That early exposure to the limits of emergency response shaped her career in public health – shifting her focus from reacting to crises to preventing them. Rachel earned her Master of Public Health from NYU’s School of Global Public Health with a concentration in Social and Behavioral Sciences. She has worked on research teams at NYU Langone Health studying substance use screening, naloxone distribution, and referral-to-treatment systems, as well as innovative transplant initiatives including HIV-to-HIV transplantation and emerging donor expansion strategies. Across her clinical and research roles, Rachel has worked with more than 1,000 patients and distributed hundreds of naloxone kits. Her work centers on a simple belief: life-saving medication only works if it’s accessible, carried, and supported by education. At nCase, Rachel helps bridge the gap between innovation and implementation – ensuring that our products are paired with evidence-based training, compassionate public health messaging, and real-world impact.

Sam brings a strong clinical and research background to his role at nCase Technologies, shaped by his experience as an EMT, oncology patient care technician, and volunteer with MONET’s needle exchange program. His dedication to harm reduction and healthcare accessibility stems from witnessing the transformative impact of accessible interventions in underserved communities. At nCase, Sam oversees supply chain management and strategic development, working to ensure NALOX-1 reaches those who need it most.

Mackenzie brings hands-on experience as a certified EMT and former emergency department patient care technician to her role at nCase Technologies. Deeply committed to health equity and emergency care, she is actively engaged in community outreach, using her clinical expertise and grassroots efforts to highlight the life-saving potential of NALOX-1 and ensure this critical message reaches those who need it most.

Caroline Cary is the Head of the nCase Research Team and was the Founding Director of Public Health Education & Research. She is currently completing her MD/MPH, bringing a rare combination of clinical training and public health expertise to the team. Caroline's background spans community health, research, and direct patient care. She conducted graduate-level research on the social determinants of health, completed a premedical clinical internship at NYU Langone/Bellevue Hospital, and served two terms as an AmeriCorps member – first addressing the opioid epidemic at Community Health Center in Connecticut, and later expanding affordable housing access at Habitat for Humanity in Seattle. She studied public health in Buenos Aires, Argentina, with coursework in epidemiology and health systems policy. A Denison University President's Medal recipient, Caroline brings both academic rigor and on-the-ground public health experience to nCase's mission of expanding naloxone access and saving lives.